Erythropoietin or darbepoetin for patients with cancer

Tonia, Thomy; Mettler, Annette; Robert, Nadège; Schwarzer, Guido; Seidenfeld, Jerome; Weingart, Olaf; Hyde, Chris; Engert, Andreas; Bohlius, Julia (2012). Erythropoietin or darbepoetin for patients with cancer. Cochrane database of systematic reviews, 12(12), CD003407. Chichester: WileyInterscience 10.1002/14651858.CD003407.pub5

[img]
Preview
Text
Tonia CochraneDatabaseSystRev 2012.pdf - Published Version
Available under License Publisher holds Copyright.
This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2012, Issue 12. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.

Download (4MB) | Preview

Anaemia associated with cancer and cancer therapy is an important clinical factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant human erythropoiesis stimulating agents (ESAs) and red blood cell transfusions.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Tonia, Thomai, Bohlius, Julia Friederike

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1469-493X

Publisher:

WileyInterscience

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:35

Last Modified:

02 Mar 2023 23:21

Publisher DOI:

10.1002/14651858.CD003407.pub5

PubMed ID:

23235597

Web of Science ID:

000312255900027

BORIS DOI:

10.7892/boris.13941

URI:

https://boris.unibe.ch/id/eprint/13941 (FactScience: 220660)

Actions (login required)

Edit item Edit item
Provide Feedback